PMID- 31263505
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220409
IS  - 1741-427X (Print)
IS  - 1741-4288 (Electronic)
IS  - 1741-427X (Linking)
VI  - 2019
DP  - 2019
TI  - A Study on the Development of a Korean Metabolic Syndrome Questionnaire Using 
      Blood Stasis Clinical Data.
PG  - 8761417
LID - 10.1155/2019/8761417 [doi]
LID - 8761417
AB  - OBJECTIVE: The aims of this study were to extract clinical indicators related to 
      metabolic diseases using the Blood Stasis Questionnaires I and II (BSQ-I and II) 
      developed in 2013 and 2014, respectively, and to develop a BSQ on metabolic 
      syndrome (BSQ-MS). METHODS: A total of 2,158 patients, comprising 1,214 from 7 
      traditional Korean medical hospitals in 2013 and 944 from 3 traditional Korean 
      medical hospitals in 2014, were asked to complete the BSQ-I and BSQ-II. For the 
      370 patients who met the metabolic syndrome criteria, reliability and validity of 
      the BSQ-MS were assessed using Cronbach's alpha, while prediction accuracy was 
      determined by logistic regression. RESULTS: The BSQ-MS included a total of 15 
      clinical signs and symptoms. It showed satisfactory internal consistency 
      (Cronbach's alpha coefficient=0.70) and validity, with significant differences in 
      mean scores between the blood stasis (14.09+/-6.14) and non-blood stasis 
      (9.09+/-5.60) subject groups. The cut-off value of BSQ-MS score was 9 points, the 
      area under the receiver operating characteristic curve was approximately 77%, the 
      sensitivity and specificity of the diagnostic accuracy according to the cut-off 
      value were 82.9% and 49.7%, respectively, and the sensitivity and specificity of 
      the prediction accuracy by logistic regression were 72.2% and 71.6%, 
      respectively. CONCLUSION: These results suggest that the BSQ-MS is an appropriate 
      instrument for estimating blood stasis in patients with metabolic syndrome, 
      although its sensitivity for diagnosis according to the cut-off value is low.
FAU - Kang, Byoung-Kab
AU  - Kang BK
AD  - Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, 
      Republic of Korea.
FAU - Jang, Soobin
AU  - Jang S
AUID- ORCID: 0000-0003-0943-9290
AD  - Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, 
      Republic of Korea.
FAU - Ko, Mi Mi
AU  - Ko MM
AUID- ORCID: 0000-0002-5758-4655
AD  - Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, 
      Republic of Korea.
FAU - Jung, Jeeyoun
AU  - Jung J
AUID- ORCID: 0000-0002-9213-4748
AD  - Clinical Medicine Division, Korea Institute of Oriental Medicine, Daejeon, 
      Republic of Korea.
LA  - eng
PT  - Journal Article
DEP - 20190527
PL  - United States
TA  - Evid Based Complement Alternat Med
JT  - Evidence-based complementary and alternative medicine : eCAM
JID - 101215021
PMC - PMC6556799
EDAT- 2019/07/03 06:00
MHDA- 2019/07/03 06:01
PMCR- 2019/05/27
CRDT- 2019/07/03 06:00
PHST- 2019/02/13 00:00 [received]
PHST- 2019/04/16 00:00 [accepted]
PHST- 2019/07/03 06:00 [entrez]
PHST- 2019/07/03 06:00 [pubmed]
PHST- 2019/07/03 06:01 [medline]
PHST- 2019/05/27 00:00 [pmc-release]
AID - 10.1155/2019/8761417 [doi]
PST - epublish
SO  - Evid Based Complement Alternat Med. 2019 May 27;2019:8761417. doi: 
      10.1155/2019/8761417. eCollection 2019.